It can be imagined that sepsis in COVID-19 leads to hypoxic injury and ischemia of the liver, causing elevated liver biochemistries, which further explains why serum ALT, AST, and total bilirubin levels are higher in severe/ICU COVID-19 patients than non-severe patients, as demonstrated in our study [6,7,17]. Here, GPT is linked to COVID-19.